These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1924637

  • 21. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
    McKenna DJ, Guan XM, Shulgin AT.
    Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838
    [Abstract] [Full Text] [Related]

  • 22. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
    Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK.
    Eur J Pharmacol; 1989 Aug 29; 167(3):375-83. PubMed ID: 2572435
    [Abstract] [Full Text] [Related]

  • 23. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.
    Li AA, Marek GJ, Vosmer G, Seiden LS.
    Pharmacol Biochem Behav; 1989 Jul 29; 33(3):641-8. PubMed ID: 2573905
    [Abstract] [Full Text] [Related]

  • 24. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT, Champney TH, Frye GD.
    Pharmacol Biochem Behav; 1989 Aug 29; 33(4):741-7. PubMed ID: 2575758
    [Abstract] [Full Text] [Related]

  • 25. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF, Meltzer HY, Gudelsky GA.
    J Pharmacol Exp Ther; 1988 Jun 29; 245(3):873-9. PubMed ID: 2898523
    [Abstract] [Full Text] [Related]

  • 26. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.
    Stone DM, Merchant KM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Dec 29; 26(12):1677-83. PubMed ID: 2893986
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    Schmidt CJ, Levin JA, Lovenberg W.
    Biochem Pharmacol; 1987 Mar 01; 36(5):747-55. PubMed ID: 2881549
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME.
    J Neurosci; 1988 Aug 01; 8(8):2788-803. PubMed ID: 2457659
    [Abstract] [Full Text] [Related]

  • 34. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K, Brennan KA, Colussi-Mas J, Schenk S.
    Addict Biol; 2010 Jul 01; 15(3):289-98. PubMed ID: 20477756
    [Abstract] [Full Text] [Related]

  • 35. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    Marona-Lewicka D, Nichols DE.
    Eur J Pharmacol; 1994 Jun 02; 258(1-2):1-13. PubMed ID: 7925587
    [Abstract] [Full Text] [Related]

  • 36. (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
    Kelland MD, Freeman AS, Chiodo LA.
    Eur J Pharmacol; 1989 Oct 04; 169(1):11-21. PubMed ID: 2574685
    [Abstract] [Full Text] [Related]

  • 37. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
    Gu XF, Azmitia EC.
    Eur J Pharmacol; 1993 Apr 22; 235(1):51-7. PubMed ID: 8100196
    [Abstract] [Full Text] [Related]

  • 38. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
    Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE.
    Pharmacol Biochem Behav; 1996 Jan 22; 53(1):99-105. PubMed ID: 8848466
    [Abstract] [Full Text] [Related]

  • 39. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
    Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA.
    Pharmacol Biochem Behav; 2001 Jan 22; 69(1-2):261-7. PubMed ID: 11420094
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC, Bankson MG, Cunningham KA.
    J Pharmacol Exp Ther; 1999 Sep 22; 290(3):965-73. PubMed ID: 10454466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.